Epidemiology, pathogenesis and prevention of congenital cytomegalovirus infection

Abstract

Cytomegalovirus is the most common cause of congenital infection. Congenital cytomegalovirus infection can follow both primary and recurrent maternal infections. It is associated with a significant burden of disease and death. The determinants of mother-to-child transmission and the pathogenesis of symptomatic fetal infection remain poorly understood. For a long time, congenital cytomegalovirus infection has been a neglected disease. Recently, the Institute of Medicine has recognized that the development of a vaccine against congenital cytomegalovirus infection is a public health priority, which should stimulate research in this area. The development of antiviral therapies to prevent symptoms in infected newborns also represents an important area of research.

• antibodies
• cidofovir
• congenital infection
• cytomegalovirus
• fomivirsen
• foscarnet
• ganciclovir
• pregnancy
• proteasome inhibitors
• T-lymphocytes
• vaccine
• valganciclovir